Coronary stenting with the sirolimus-eluting stent in clinical practice: Final results from the prospective multicenter german cypher stent registry

Journal of Interventional Cardiology

Volumn 23, Issue 1, 2010, Pages 18-25

  Zahn, Ralf ^a   Hamm, Christian W ^b   Schneider, Steffen ^c   Richardt, Gert ^d   Kelm, Malte ^e   Levenson, Benny ^f   Bonzel, Tassilo ^g   Tebbe, Ulrich ^h   Sabin, Georg ⁱ   Nienaber, Christoph A ^j  

^a Herzzentrum   (Germany)

^b KERCKHOFF HEART CENTER   (Germany)

^c Institut fur Herzinfarktforschung   (Germany)

^d Segeberger Kliniken   (Germany)

^e UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^f Kardiologische Praxis   (Germany)

^g Kardiologie   (United States)

^h KLINIKUM LIPPE DETMOLD   (Germany)

ⁱ ELISABETH KRANKENHAUS ESSEN   (Germany)

^j ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOGENIC SHOCK; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HOSPITAL DISCHARGE; HUMAN; IMPLANT; KIDNEY FAILURE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION; STROKE; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, BALLOON, CORONARY; CONFIDENCE INTERVALS; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; CORONARY STENOSIS; DIABETES MELLITUS; DRUG-ELUTING STENTS; FEMALE; GERMANY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PROSPECTIVE STUDIES; REGISTRIES; RENAL INSUFFICIENCY; RISK FACTORS; ROC CURVE; SEVERITY OF ILLNESS INDEX; SHOCK, CARDIOGENIC; SIROLIMUS; STROKE; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 76749101174     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2009.00513.x     Document Type: Article

References (31)

1. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002 346 : 1773 1780.
2. Grube E, Silber S, Hauptmann KE, et al. TAXUS I: Six- and twelve-month results from arandomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 2003 107 : 38 42.
3. Hong MK, Mintz GS, Lee CW, et al. Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: A serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT). Circulation 2003 107 : 517 520.
4. Park SJ, Shim WH, Ho DS, et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 2003 348 : 1537 1545.
5. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003 349 : 1315 1323.
6. Colombo A, Drzewiecki J, Banning A, et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003 108 : 788 794.
7. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004 350 : 221 231.
8. Schofer J, Schlüter M, Gershlick AH, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: Double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003 362 : 1093 1099.
9. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007 356 : 998 1008.
10. Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents: A collaborative network meta-analysis. Lancet 2007 370 : 937 948.
11. Zahn R, Hamm CW, Schneider S, et al. The sirolimus-eluting coronary stent in daily routine practice in Germany: Trends in indications over the years. Results from the prospective multi-centre German Cypher Stent Registry. Clin Res Cardiol 2007 96 : 548 556.
12. Marroquin OC, Selzer F, Mulukutla SR, et al. A comparison of bare-metal and drug-eluting stents for off-label indications. N Engl J Med 2008 358 : 342 352.
13. Shishehbor MH, Goel SS, Kapadia SR, et al. Long-term impact of drug-eluting stents versus bare-metal stents on all-cause mortality. J Am Coll Cardiol 2008 52 : 1041 1048.
14. Degertekin M, Regar E, Tanabe K, et al. Sirolimus-eluting stent for treatment of complex in-stent restenosis: The first clinical experience. J Am Coll Cardiol 2003 41 : 184 189.
15. Zahn R, Hamm CW, Zeymer U, et al. "Real life" use of sirolimus-eluting coronary stents in Germany: Results from the prospective multi-centre German Cypher Registry. Z Kardiol 2004 93 : 287 294.
16. Zahn R, Hamm CW, Schneider S, et al. Incidence and predictors of target vessel revascularization and clinical event rates of the sirolimus-eluting coronary stent (results from the prospective multicenter German Cypher Stent Registry). Am J Cardiol 2005 95 : 1302 1308.
17. Zahn R, Hamm CW, Schneider S, et al. Predictors of death or myocardial infarction during follow-up after coronary stenting with the sirolimus-eluting stent: Results from the prospective multicenter German Cypher Stent Registry. Am Heart J 2006 152 : 1146 1152.
18. Zellerhoff C, Schneider S, Senges J, et al. Sirolimus-eluting stents in the treatment of chronic total coronary occlusions: Results from the prospective multi-center German Cypher Stent Registry. Clin Res Cardiol 2008 97 : 253 259.
19. Zahn R, Hamm CW, Zeymer U, et al. [Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Stent Registry.] Herz 2004 29 : 181 186. (Pubitemid 38495892)
20. Hoffmann R, Hamm C, Nienaber C, et al. Implantation of sirolimus-eluting stents in sapheneous vein grafts. Clinical follow-up results from the German Cypher Stent Registry. Coron Artery Dis 2007 18 : 559 564. (Pubitemid 47556388)
21. Khattab AA, Hamm CW, Senges J, et al. Prognostic value of the modified American College of Cardiology/American Heart Association lesion morphology classification for clinical outcome after sirolimus-eluting stent placement (results of the prospective multicenter German Cypher Registry). Am J Cardiol 2008 101 : 477 482.
22. Khattab AA, Hamm CW, Senges J, et al. Sirolimus-eluting stent treatment for unprotected versus protected left main coronary artery disease in widespread clinical routine: 6-month and 3-year clinical follow-up results from the prospective multicentre German Cypher Registry. Heart 2007 93 : 1251 1255.
23. Mollmann H, Elsasser A, Nef H, et al. Treatment of in-stent restenosis with sirolimus-eluting stents: Results from the prospective German Cypher Stent Registry. Clin Res Cardiol 2008 97 : 432 440.
24. Singh M, Gersh BJ, McClelland RL, et al. Clinical and angiographic predictors of restenosis after percutaneous coronary intervention: Insights from the Prevention of Restenosis with Tranilast and Its Outcomes (PRESTO) trial. Circulation 2004 109 : 2727 2731.
25. Kounis GN, Hahalis G, Soufras GD, et al. Kounis syndrome and simultaneous multivessel acute coronary syndromes after successful drug-eluting stent implantation. Int J Cardiol 2008 127 : 146 148.
26. Kounis NG, Hahalis G, Theoharides TC. Coronary stents, hypersensitivity reactions, and the Kounis syndrome. J Interv Cardiol 2007 20 : 314 323.
27. Chen JP, Hou D, Pendyala L, et al. Drug-eluting stent thrombosis: The Kounis hypersensitivity-associated acute coronary syndrome revisited. JACC. Cardiovasc Interv 2009 2 : 583 593.
28. Jeremias A, Sylvia B, Bridges J, et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 2004 109 : 1930 1932.
29. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004 364 : 1519 1521. (Pubitemid 39410418)
30. Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007 115 : 2344 2351.
31. Kirtane AJ, Gupta A, Iyengar S, et al. Safety and efficacy of drug-eluting and bare metal stents: Comprehensive meta-analysis of randomized trials and observational studies. Circulation 2009 119 : 3198 3206.